A C3 convertase assay for nephritic factor functional activity

被引:18
|
作者
Jelezarova, E
Schlumberger, M
Sadallah, S
Späth, PJ
Schifferli, JA
Lutz, HU [1 ]
机构
[1] ETH Zentrum, Swiss Fed Inst Technol, Inst Biochem, CH-8092 Zurich, Switzerland
[2] Univ Basel Hosp, Dept Med, CH-4031 Basel, Switzerland
[3] SRC, ZLB Cent Lab, Blood Transfus Serv, Bern, Switzerland
关键词
C3 nephritic factor; C3; convertase; complement; C3b(2)-IgG;
D O I
10.1016/S0022-1759(01)00295-2
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
C3 nephritic factor (C3NeF) is an autoantibody against the C3 convertase which stabilizes this otherwise inherently labile neoenzyme and induces a continuous activation of the alternative pathway with C3 depletion. NeF is found in patients with membranoproliferative glomerulonephritis and/or partial lipodystrpohy. NeF activity is usually detected in plasma by hemolytic tests. In order to obtain reproducible data for the functional activity of purified C3NeF IgG a solid phase assay was developed. C3 convertase was generated on immobilized C3b by incubation with factors B and D in the presence of Ni2+. Convertase sites were left to decay in the presence of normal IgG or NeF IgG. Residual convertase activity was measured by adding I-125-C3 and capturing nascent I-125-C3b on the plate surface via covalently coupled NH2-Glu-Tyr dipeptide, In the presence of factor H during C3 convertase decay, a dose dependent stabilizing activity was shown for NeF IgG including NeF IgG purified from urine. A second format of the assay was developed in which C3 convertase was assembled on C3b(2)-IgG complexes in the presence of Mg2+. Since these complexes are more efficient as convertase precursors the signal was five-fold higher than with C3b. Convertase decay, on the other hand, was not influenced by the nature of the precursor and in both systems the stabilizing activity of NeF IgG was similar. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:45 / 52
页数:8
相关论文
共 50 条
  • [41] Functional consequences of C5 nephritic factors in C3 glomerulopathies
    Ellen F. Carney
    Nature Reviews Nephrology, 2017, 13 : 597 - 597
  • [42] An ex vivo C3 convertase assay to evaluate the effectiveness of factor D inhibition in vivo in patients with C3 glomerulopathy (C3G)
    Donadelli, Roberta
    Daina, Erica
    Gambo, Sara
    Benigni, Ariela
    Remuzzi, Giuseppe
    Noris, Marina
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2024, 54 : 77 - 77
  • [43] IGG SUBCLASS STUDIES OF C3 NEPHRITIC FACTOR (C3NEF)
    DAVIS, AE
    GELFAND, EW
    SCHUR, PH
    ROSEN, FS
    ALPER, CA
    JOURNAL OF IMMUNOLOGY, 1978, 120 (05): : 1770 - 1771
  • [44] C3 NEPHRITIC FACTOR IN PROLIFERATIVE GLOMERULONEPHRITIS WITH MONOCLONAL IGG DEPOSITS
    Anderson, Emily
    Katz, Avi
    Kim, Youngki
    Nester, Carla
    Nasr, Samih
    Goodfellow, Renee
    Meyer, Nicole
    Smith, Richard
    Zhang, Yuzhou
    MOLECULAR IMMUNOLOGY, 2019, 114 : 444 - 444
  • [45] UTILIZATION OF PROPERDIN BY C3 NEPHRITIC FACTOR IN PATIENTS WITH MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS
    SPITZER, R
    STITZEL, A
    PEDIATRIC RESEARCH, 1974, 8 (04) : 461 - 461
  • [46] Detection of C3 nephritic factor in patients with dense deposit disease
    Zhang, Yuzhou
    Smith, Richard J. H.
    MOLECULAR IMMUNOLOGY, 2010, 47 (13) : 2202 - 2202
  • [47] REGULATION OF THE C-3 NEPHRITIC FACTOR STABILIZED C3/C5 CONVERTASE OF COMPLEMENT BY PURIFIED HUMAN-ERYTHROCYTE C3B RECEPTOR
    DAHA, MR
    KOK, DJ
    VANES, LA
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1982, 50 (01): : 209 - 214
  • [48] ISOLATION OF ALTERNATIVE PATHWAY C3 CONVERTASES FORMED IN PRESENCE OF C3 NEPHRITIC FACTOR (C3NEF)
    DAHA, MR
    FEARON, DT
    AUSTEN, KF
    JOURNAL OF IMMUNOLOGY, 1976, 116 (06): : 1730 - 1731
  • [49] HYPOCOMPLEMENTEMIA OF POSTSTREPTOCOCCAL ACUTE GLOMERULONEPHRITIS IS ASSOCIATED WITH C3 NEPHRITIC FACTOR (C3NEF) IGG AUTOANTIBODY ACTIVITY
    FREMEAUXBACCHI, V
    WEISS, L
    DEMOUCHY, C
    MAY, A
    PALOMERA, S
    KAZATCHKINE, MD
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1994, 9 (12) : 1747 - 1750
  • [50] PARTIAL LIPOATROPHY ASSOCIATED WITH HYPOCOMPLEMENTEMIA AND C3 NEPHRITIC FACTOR (C3NEF)
    WUEPPER, KD
    BARDANA, EJ
    CLINICAL RESEARCH, 1975, 23 (03): : A464 - A464